A 3D quantitative imaging biomarker in pre-treatment MRI predicts overall survival after stereotactic radiation therapy of patients with a singular brain metastasis.

CONCLUSIONS: Patients with lesions that show a higher percentage of enhancement in pre-treatment MRI demonstrated improved iPFS and OS compared to those with mainly hypo-enhancing lesions. Lesion enhancement may be a radiomic marker, useful in prognostic indices for survival prediction, in patients with singular BM. PMID: 30841703 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30841703?dopt=Abstract

Source: Acta Radiologica - March 5, 2019 Category: Radiology Authors: Della Seta M, Collettini F, Chapiro J, Angelidis A, Engeling F, Hamm B, Kaul D Tags: Acta Radiol Source Type: research